论文部分内容阅读
目的观察抗敏止咳方治疗咳嗽变异型哮喘的临床疗效。方法将82例咳嗽变异型哮喘患者随机分为治疗组、对照组。对照组40例予西医常规治疗,治疗组42例在西医常规治疗基础上予以抗敏止咳方煎剂口服;两组均治疗3周,观察临床疗效及咳嗽症状减轻、消退及夜间咳嗽消失时间,并于结束治疗后6个月随访复发率。结果治疗组、对照组总有效率分别为90.47%、70.00%;组间临床疗效比较,差异有统计学意义(P<0.05)。在结束治疗后的6个月中,治疗组、对照组复发率分别为11.90%、40.00%;组间复发率比较,差异有统计学意义(P<0.01)。治疗组咳嗽症状减轻、消退及夜间咳嗽消失时间与对照组比较,差异有统计学意义(P<0.01)。结论抗敏止咳方治疗咳嗽变异型哮喘临床疗效良好。
Objective To observe the clinical efficacy of Kang Min Zhi Ke Fang in treating cough variant asthma. Methods 82 patients with cough variant asthma were randomly divided into treatment group and control group. The control group of 40 cases of Western medicine routine treatment, the treatment group of 42 patients on the basis of conventional Western medicine to be anti-sensitive cough decoction orally; both groups were treated for 3 weeks to observe the clinical efficacy and cough symptoms, regression and nocturnal cough disappear time, And follow-up of the recurrence rate 6 months after the end of treatment. Results The total effective rates in the treatment group and the control group were 90.47% and 70.00% respectively. There was significant difference between the two groups in clinical efficacy (P <0.05). In the 6 months after the end of treatment, the recurrence rates in the treatment group and the control group were 11.90% and 40.00%, respectively. The recurrence rates were statistically significant (P <0.01). The treatment group cough symptom relief, regression and nighttime cough disappear time compared with the control group, the difference was statistically significant (P <0.01). Conclusion Anti-cough Prescription Cough variant asthma clinical efficacy.